Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asia Pacific

Set Alert for Asia Pacific

Medtech Reg Progress In Russia, CIS And Eurasian Union At Operational Level

Various economies of the Commonwealth of Independent States (CIS) and the Eurasian Economic Union (EAEU) are pressing ahead with medtech regulatory changes nationally and/or regionally, which can only be good for the delivery of quality care over the long term. But a question mark still hangs over the official start date of the EAEU medtech regulatory system; a formal postponement may be decided soon.

EAEU Belarus Kazakhstan
Advertisement

AdvaMed To Plead With USTR To Spare Medtech In China Tariffs

In prepared remarks shared with Medtech Insight, AdvaMed plans to argue that tariffs imposed on medtech products made in China would disrupt an ongoing "action plan" the industry is pursuing to achieve reciprocal market access between the US and China for the industry.

Trade Policy

Hong Kong To Test If Devices Approved In China Satisfy Local Requirements For Listing

Hong Kong's medtech regulator wants to know whether medical device marketing authorizations issued by China can be used by companies to demonstrate compliance with local conformity assessment requirements.

Policy & Regulation Hong Kong

Global Medtech Guidance Tracker: April 2018

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Thirty-one new guidance documents were posted on the tracker since its last update.
United Kingdom United States

QUOTED. April 19, 2018. Abel Ang.

For device-makers that want to capitalize on opportunities arising from Asia's ever-burgeoning health-care systems, relationships are indeed critical to a successful APAC business strategy. Check out what Accuron Medtech CEO Abel Ang said about it here.

Quoted Asia Pacific

Exec Chat: Breaking Into Asia? Think Long-Term And Engage, Accuron Medtech Chief Advises

For many medtech companies, Asia still holds significant opportunity compared to the persistent slow growth in the more mature US and European markets. But those looking to do business in this region need to plan long term. The biggest mistake is to think you can make a quick buck, says Abel Ang, CEO of Accuron Medtech, Southeast Asia's largest medical device pure-play. The Singapore-based industry veteran shares with Medtech Insight the lessons he learned from his time building businesses for medtech multinationals in APAC and other international markets. He also gives tips from his current experience introducing a disruptive technology to this region.

Asia Pacific Market Access

Device Debut: Philips, Digital China Health Push Teleradiology App To Chinese Market

Philips and Digital China Health, the largest provider of cloud-based healthcare services in China, have launched the Shinefly teleradiology application and services platform to help Chinese health-care providers manage their radiology workload and information output.

China Diagnostic Imaging
See All

UsernamePublicRestriction

Register